Providence St. Vincent Medical Center, is a non-profit, acute care teaching hospital in an unincorporated section of Washington County, Oregon, in the West Haven-Sylvan area north of Beaverton, Oregon and west of Portland, Oregon, United States – and within the Portland metropolitan area.

There are 523 beds in Providence Saint Vincent Medical Center.

During the past decade, Providence Saint Vincent Medical Center conducted 242 clinical trials. In the 10-year time frame, 242 clinical trials started and 189 clinical trials were completed, i.e. on average, 78.1% percent of trials that started reached the finish line to date. In the past 5 years, 107 clinical trials started and 102 clinical trials were completed. i.e. 95.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Saint Vincent Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 143 trials, followed by "SWOG Cancer Research Network" with 81 trials sponsored, "Alliance for Clinical Trials in Oncology" with 61 trials sponsored, "Abbott Medical Devices" with 20 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored. Other sponsors include 121 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Saint Vincent Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 213 trials as a collaborator, "NRG Oncology" with 42 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 10 trials as a collaborator. Other collaborators include 171 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "Providence Saint Vincent Medical Center" are "Breast Cancer" (34 trials), "Lymphoma" (16 trials), "Coronary Artery Disease" (13 trials), "Lung Cancer" (12 trials) and "Recurrent Breast Carcinoma" (11 trials). Many other conditions were trialed in "Providence Saint Vincent Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Saint Vincent Medical Center" are "Drug" (323 trials), "Other" (192 trials), "Biological" (145 trials), "Procedure" (100 trials) and "Radiation" (76 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (80 trials), "Quality-of-Life Assessment" (71 trials), "Questionnaire Administration" (45 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (39 trials). Other intervention names were less common.

The vast majority of trials in "Providence Saint Vincent Medical Center" are 374 trials for "All" genders, 68 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Saint Vincent Medical Center". undefined are not yet recruiting, 89 are recruiting, 147 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 171 completed trials in Providence Saint Vincent Medical Center, 9 suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Saint Vincent Medical Center, 12 "Phase 1" clinical trials were conducted, 180 "Phase 2" clinical trials and 216 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 48 trials that are defined as “Not Applicable".

Providence Saint Vincent Medical Center has several departments that took part in Clinical trials: "Providence Oncology and Hematology Care Clinic - Westside" - 23 trials